Research Options:
Week of Expected Pricing Withdrawn
Company Name Revo Biologics, Inc
Proposed Ticker RBIO
CUSIP 76155H105
Business Description A commercial-stage biopharmaceutical company focused on the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions.
Lead Underwriter Guggenheim Securities, LLC , Piper Jaffray & Co.
Co-Managers BTIG, LLC , Roth Capital Partners, Inc
Initial Shares 36,00,000
Revised Initial Shares N/A
Initial Price $13.00-$15.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.